Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis
奥希替尼辅助治疗EGFR突变阳性IB期至IIIA期非小细胞肺癌患者(肿瘤完全切除后):ADAURA中国亚组分析
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100621
Wang, Jie; Wu, Yi-Long; Lu, Shun; Wang, Qun; Li, Shanqing; Zhong, Wen-Zhao; Wang, Qiming; Li, Wei; Wang, Buhai; Chen, Jun; Cheng, Ying; Duan, Hongbing; Li, Gaofeng; Shan, Li; Liu, Yangbo; Liu, Jing; Huang, Xiangning; Bolanos, Ana; He, Jie